Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.69% |
| 2 | Industrials | 9.96% |
| 3 | Consumer Discretionary | 8.03% |
| 4 | Healthcare | 7.46% |
| 5 | Financials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Galicia Financial Group
GGAL
$6.66B
| $1.06M | ﹤0.01% |
+21,134
| New | +$995K |
|
2102
PUT
Alnylam Pharmaceuticals
ALNY
$31.6B
| $1.05M | ﹤0.01% |
+3,500
| New | +$1.06M |
|
2103
CALL
Charter Communications
CHTR
$17.9B
| $1.05M | ﹤0.01% |
+7,400
| New | +$1.23M |
|
2104
Schneider National
SNDR
$6.28B
| $1.05M | ﹤0.01% |
+28,786
| New | +$939K |
|
2105
Consolidated Edison
ED
$39.3B
| $1.05M | ﹤0.01% |
9,492
-486,508
| -98% | -$52.9M |
|
2106
PUT
Shake Shack
SHAK
$3.06B
| $1.05M | ﹤0.01% |
18,700
+9,800
| +110% | +$738K |
|
|
OKLO
2107
PUT
Oklo
OKLO
$7.83B
| $1.05M | ﹤0.01% |
20,000
| – | – |
|
2108
PUT
Upstart Holdings
UPST
$2.95B
| $1.05M | ﹤0.01% |
29,500
-11,300
| -28% | -$348K |
|
2109
CALL
BHP
BHP
$246B
| $1.04M | ﹤0.01% |
+12,500
| New | +$1.04M |
|
2110
CALL
YPF Sociedad Anonima ADS
YPF
$20.1B
| $1.04M | ﹤0.01% |
22,900
+5,500
| +32% | +$258K |
|
2111
Wabtec
WAB
$50.3B
| $1.04M | ﹤0.01% |
3,849
-105,152
| -96% | -$27.8M |
|
2112
MetLife
MET
$60B
| $1.04M | ﹤0.01% |
12,261
-3,759
| -23% | -$303K |
|
2113
Sabra Healthcare REIT
SBRA
$5.21B
| $1.04M | ﹤0.01% |
53,074
+39,070
| +279% | +$775K |
|
2114
D-Wave Quantum Inc
QBTS
$7.59B
| $1.03M | ﹤0.01% |
43,125
+4,544
| +12% | +$99.7K |
|
2115
Las Vegas Sands
LVS
$30.5B
| $1.03M | ﹤0.01% |
22,305
+8,808
| +65% | +$457K |
|
2116
Agilent Technologies
A
$44.9B
| $1.03M | ﹤0.01% |
7,752
-655,191
| -99% | -$79.8M |
|
2117
TechnipFMC
FTI
$30.4B
| $1.03M | ﹤0.01% |
+15,524
| New | +$1.1M |
|
|
NNE
2118
Nano Nuclear Energy
NNE
$1.01B
| $1.03M | ﹤0.01% |
48,507
-47,310
| -49% | -$1.17M |
|
|
KORE
2119
DELISTED
KORE Group Holdings
KORE
| $1.02M | ﹤0.01% |
110,765
-1,427
| -1% | -$13.1K |
|
|
VACI
2120
Viking Acquisition Corp I
VACI
$321M
| $1.02M | ﹤0.01% |
+100,000
| New | +$1.02M |
|
|
MRP
2121
Millrose Properties Inc
MRP
$5.05B
| $1.02M | ﹤0.01% |
33,915
-248,143
| -88% | -$7.18M |
|
|
PSIX
2122
Power Solutions International
PSIX
$840M
| $1.02M | ﹤0.01% |
26,201
+17,802
| +212% | +$979K |
|
|
CBLL
2123
CeriBell Inc
CBLL
$929M
| $1.02M | ﹤0.01% |
+52,321
| New | +$993K |
|
2124
PUT
Datadog
DDOG
$84.6B
| $1.02M | ﹤0.01% |
3,900
-19,300
| -83% | -$3.59M |
|
2125
CALL
Alector
ALEC
$264M
| $1.01M | ﹤0.01% |
+503,900
| New | +$1.08M |
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $7.14B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.7% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.